India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly lower prices. Analysts predict the market will reach Rs 12,000 ...
Trade Brains on MSN
Pharma stocks: Which company is likely to lead India's weight-loss injection market?
India, March 23 -- India's semaglutide market has seen heightened competition, with the expiration of the patent causing a flood of generics at discounted prices. The prices vary between Rs 1,290 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results